Owens & Minor posted total revenue of just over $2.6 billion for the first quarter 2025, roughly flat to the same quarter in ...

Medical supply and logistics company Owens & Minor (NYSE:OMI) in Q1 CY2025, with sales flat year on year at $2.63 billion. On ...

GLEN ALLEN, Va. (AP) — GLEN ALLEN, Va. (AP) — Owens & Minor Inc. (OMI) on Thursday reported a loss of $25 million in its first quarter. On a per-share basis, the Glen Allen, Virginia-based company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Owens & Minor's stock initially surged 40% after announcing plans to divest its low-margin Products & Healthcare Services unit, despite a recent $307 million goodwill impairment charge.

We have customers that have grown and include companies such as Stata, Cintas, AbbVie, Owens and Minor, and Medtronic, and that has fueled the company’s growth over the last three years.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Stay informed on the latest scams with a free biweekly newsletter ...

Minor League Baseball is back in business, and that can mean only one thing: so is Prospect Watch. For those new to these parts, Prospect Watch is our biweekly feature that highlights at least one ...

Owens & Minor, Inc.'s aggressive dealmaking and substantial debt have led to a mixed track record and declining stock performance, raising skepticism about future prospects. The company's ...

Citi analyst Daniel Grosslight maintained a Buy rating on Owens & Minor (OMI – Research Report) today and set a price target of $11.00. The company’s shares closed yesterday at $6.77.

Citi lowered the firm’s price target on Owens & Minor to $11 from $13 and keeps a Buy rating on the shares. The firm does not think the company’s Q1 earnings will do much to assuage concerns ...

$200,000 of OWENS & MINOR INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to the medical-surgical ...